Home > > > Report Detail

Global Inflammatory Bowel Disease Therapeutics Market Growth (Status and Outlook) 2023-2029

Publisher Name :
Date: 01-Feb-2023
No. of pages: 88

LPI (LP Information)' newest research report, the "Inflammatory Bowel Disease Therapeutics Industry Forecast" looks at past sales and reviews total world Inflammatory Bowel Disease Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Inflammatory Bowel Disease Therapeutics sales for 2023 through 2029. With Inflammatory Bowel Disease Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inflammatory Bowel Disease Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Inflammatory Bowel Disease Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inflammatory Bowel Disease Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inflammatory Bowel Disease Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inflammatory Bowel Disease Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inflammatory Bowel Disease Therapeutics.

The global Inflammatory Bowel Disease Therapeutics market size is projected to grow from US$ 16900 million in 2022 to US$ 21830 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.

United States market for Inflammatory Bowel Disease Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Inflammatory Bowel Disease Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Inflammatory Bowel Disease Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Inflammatory Bowel Disease Therapeutics players cover Abbvie, Johnson & Johnson, GlaxoSmithKline, Merck and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Inflammatory Bowel Disease Therapeutics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

- Anti-inflammatory Biologics

- Non-Steroidal Anti-inflammatory drugs (NSAIDs)

- Corticosteroids

Segmentation by application

- Hospital Use

- Home Use

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Abbvie

- Johnson & Johnson

- GlaxoSmithKline

- Merck

- Novartis

Global Inflammatory Bowel Disease Therapeutics Market Growth (Status and Outlook) 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inflammatory Bowel Disease Therapeutics Market Size 2018-2029
2.1.2 Inflammatory Bowel Disease Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Inflammatory Bowel Disease Therapeutics Segment by Type
2.2.1 Anti-inflammatory Biologics
2.2.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
2.2.3 Corticosteroids
2.3 Inflammatory Bowel Disease Therapeutics Market Size by Type
2.3.1 Inflammatory Bowel Disease Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Inflammatory Bowel Disease Therapeutics Segment by Application
2.4.1 Hospital Use
2.4.2 Home Use
2.5 Inflammatory Bowel Disease Therapeutics Market Size by Application
2.5.1 Inflammatory Bowel Disease Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
3 Inflammatory Bowel Disease Therapeutics Market Size by Player
3.1 Inflammatory Bowel Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Inflammatory Bowel Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Inflammatory Bowel Disease Therapeutics by Regions
4.1 Inflammatory Bowel Disease Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Inflammatory Bowel Disease Therapeutics Market Size Growth (2018-2023)
4.3 APAC Inflammatory Bowel Disease Therapeutics Market Size Growth (2018-2023)
4.4 Europe Inflammatory Bowel Disease Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Growth (2018-2023)
5 Americas
5.1 Americas Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023)
5.2 Americas Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023)
5.3 Americas Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023)
6.2 APAC Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023)
6.3 APAC Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapeutics by Country (2018-2023)
7.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023)
7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Inflammatory Bowel Disease Therapeutics Market Forecast
10.1 Global Inflammatory Bowel Disease Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Inflammatory Bowel Disease Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Inflammatory Bowel Disease Therapeutics Forecast
10.1.3 APAC Inflammatory Bowel Disease Therapeutics Forecast
10.1.4 Europe Inflammatory Bowel Disease Therapeutics Forecast
10.1.5 Middle East & Africa Inflammatory Bowel Disease Therapeutics Forecast
10.2 Americas Inflammatory Bowel Disease Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Inflammatory Bowel Disease Therapeutics Market Forecast
10.2.2 Canada Inflammatory Bowel Disease Therapeutics Market Forecast
10.2.3 Mexico Inflammatory Bowel Disease Therapeutics Market Forecast
10.2.4 Brazil Inflammatory Bowel Disease Therapeutics Market Forecast
10.3 APAC Inflammatory Bowel Disease Therapeutics Forecast by Region (2024-2029)
10.3.1 China Inflammatory Bowel Disease Therapeutics Market Forecast
10.3.2 Japan Inflammatory Bowel Disease Therapeutics Market Forecast
10.3.3 Korea Inflammatory Bowel Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Forecast
10.3.5 India Inflammatory Bowel Disease Therapeutics Market Forecast
10.3.6 Australia Inflammatory Bowel Disease Therapeutics Market Forecast
10.4 Europe Inflammatory Bowel Disease Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Inflammatory Bowel Disease Therapeutics Market Forecast
10.4.2 France Inflammatory Bowel Disease Therapeutics Market Forecast
10.4.3 UK Inflammatory Bowel Disease Therapeutics Market Forecast
10.4.4 Italy Inflammatory Bowel Disease Therapeutics Market Forecast
10.4.5 Russia Inflammatory Bowel Disease Therapeutics Market Forecast
10.5 Middle East & Africa Inflammatory Bowel Disease Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Inflammatory Bowel Disease Therapeutics Market Forecast
10.5.2 South Africa Inflammatory Bowel Disease Therapeutics Market Forecast
10.5.3 Israel Inflammatory Bowel Disease Therapeutics Market Forecast
10.5.4 Turkey Inflammatory Bowel Disease Therapeutics Market Forecast
10.5.5 GCC Countries Inflammatory Bowel Disease Therapeutics Market Forecast
10.6 Global Inflammatory Bowel Disease Therapeutics Forecast by Type (2024-2029)
10.7 Global Inflammatory Bowel Disease Therapeutics Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Abbvie
11.1.1 Abbvie Company Information
11.1.2 Abbvie Inflammatory Bowel Disease Therapeutics Product Offered
11.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbvie Main Business Overview
11.1.5 Abbvie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product Offered
11.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product Offered
11.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Inflammatory Bowel Disease Therapeutics Product Offered
11.4.3 Merck Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Inflammatory Bowel Disease Therapeutics Product Offered
11.5.3 Novartis Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Inflammatory Bowel Disease Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Anti-inflammatory Biologics
Table 3. Major Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Table 4. Major Players of Corticosteroids
Table 5. Inflammatory Bowel Disease Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Inflammatory Bowel Disease Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Inflammatory Bowel Disease Therapeutics Key Players Head office and Products Offered
Table 14. Inflammatory Bowel Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Inflammatory Bowel Disease Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Inflammatory Bowel Disease Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Inflammatory Bowel Disease Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Inflammatory Bowel Disease Therapeutics
Table 46. Key Market Challenges & Risks of Inflammatory Bowel Disease Therapeutics
Table 47. Key Industry Trends of Inflammatory Bowel Disease Therapeutics
Table 48. Global Inflammatory Bowel Disease Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Inflammatory Bowel Disease Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Inflammatory Bowel Disease Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abbvie Details, Company Type, Inflammatory Bowel Disease Therapeutics Area Served and Its Competitors
Table 53. Abbvie Inflammatory Bowel Disease Therapeutics Product Offered
Table 54. Abbvie Inflammatory Bowel Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abbvie Main Business
Table 56. Abbvie Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Inflammatory Bowel Disease Therapeutics Area Served and Its Competitors
Table 58. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Johnson & Johnson Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Inflammatory Bowel Disease Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Merck Details, Company Type, Inflammatory Bowel Disease Therapeutics Area Served and Its Competitors
Table 68. Merck Inflammatory Bowel Disease Therapeutics Product Offered
Table 69. Merck Main Business
Table 70. Merck Inflammatory Bowel Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Latest Developments
Table 72. Novartis Details, Company Type, Inflammatory Bowel Disease Therapeutics Area Served and Its Competitors
Table 73. Novartis Inflammatory Bowel Disease Therapeutics Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Inflammatory Bowel Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Novartis Latest Developments
List of Figures
Figure 1. Inflammatory Bowel Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Inflammatory Bowel Disease Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Inflammatory Bowel Disease Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Inflammatory Bowel Disease Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type in 2022
Figure 10. Inflammatory Bowel Disease Therapeutics in Hospital Use
Figure 11. Global Inflammatory Bowel Disease Therapeutics Market: Hospital Use (2018-2023) & ($ Millions)
Figure 12. Inflammatory Bowel Disease Therapeutics in Home Use
Figure 13. Global Inflammatory Bowel Disease Therapeutics Market: Home Use (2018-2023) & ($ Millions)
Figure 14. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application in 2022
Figure 15. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Player in 2022
Figure 16. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Inflammatory Bowel Disease Therapeutics Market Size 2018-2023 ($ Millions)
Figure 18. APAC Inflammatory Bowel Disease Therapeutics Market Size 2018-2023 ($ Millions)
Figure 19. Europe Inflammatory Bowel Disease Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Americas Inflammatory Bowel Disease Therapeutics Value Market Share by Country in 2022
Figure 22. United States Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Region in 2022
Figure 27. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type in 2022
Figure 28. APAC Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application in 2022
Figure 29. China Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Country in 2022
Figure 36. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Figure 37. Europe Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Figure 38. Germany Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Inflammatory Bowel Disease Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 52. APAC Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 53. Europe Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. United States Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Canada Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. China Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Japan Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Korea Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. India Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Australia Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Germany Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. France Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. UK Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Italy Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Russia Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Spain Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Israel Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Inflammatory Bowel Disease Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share Forecast by Application (2024-2029)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs